Remove Blog Remove Generic Medicine Remove Pharmaceutical Companies
article thumbnail

Union Budget 2025-26: A roadmap for India’s pharmaceutical leadership

Express Pharma

The Indian pharmaceutical sector is loaded with talent and has made great strides in generic medicine development. However, massive R&D expenditure is necessary to drive the next generation of discoveries.

article thumbnail

The rise of Fixed-Dose Combinations (FDCs): What it means for pharma players

Express Pharma

Additionally, pharmaceutical companies have increasingly turned to FDCs as a way to differentiate their products in a highly competitive market. By introducing unique formulations that combine existing drugs, companies can extend product life cycles and maintain exclusivity over certain combinations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Is India capable of ensuring equitable access to biopharmaceuticals?

Express Pharma

In a bid to resolve both physical and financial restrictions inhibiting equitable access to quality medicines, the Jan Aushadhi scheme was launched in 2008 and envisaged the setting up of dedicated Janaushadhi Kendras to provide quality generic medicines at capped prices for the general public.

article thumbnail

How global healthcare partners and Indian pharma companies are contributing to affordable medicines

Express Pharma

As the world’s leading supplier of generic drugs, India’s pharmaceutical industry has become a ray of hope for millions as it ensures quality-assured and cost-effective treatments reach those who need them the most.

Vaccines 105
article thumbnail

Global healthcare partners and Indian pharma companies: Making medicines affordable

Express Pharma

As the world’s leading supplier of generic drugs, India’s pharmaceutical industry has become a ray of hope for millions as it ensures quality-assured and cost-effective treatments reach those who need them the most. Such partnerships are particularly valuable in addressing the healthcare needs of low- and middle-income countries.

Vaccines 105